EWKS yields 20000000.00% · JNJ yields 2.13%● Live data
📍 EWKS pulled ahead of the other in Year 1
Combined, EWKS + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of EWKS + JNJ for your $10,000?
Earthworks Entertainment, Inc., a development stage company, engages in the creation, co-production, marketing, and distribution of children's and family-oriented entertainment properties. It markets its properties through multiplatform Earthworks Entertainment, Inc., a development stage company, engages in the creation, co-production, marketing, and distribution of children's and family-oriented entertainment properties. It markets its properties through multiplatform market categories, including television, home video, merchandise licensing, electronic and video games, and book and music publishing. The company also forms teaming agreements with outside companies for the co-operative marketing of entertainment properties. Earthworks Entertainment owns marketing rights to nine family-oriented entertainment properties, which include Z-Force, an action adventure property; Nine Dog Christmas, a music-driven holiday property; Big Dogs, the big attitude character brand; Little Suzy's Zoo, the preschool and baby character brand; Corneil & Bernie; The Plonsters, the clay animation television series; The Little Reindeer, an animated Christmas special; 64 Zoo Lane, the animated children's series; and Kiddo the Super Truck, a theatrical quality computer animated property. The company was incorporated in 1986 and is based in Addison, Texas.
Full EWKS Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.